Moderna (NASDAQ:MRNA) is a biotechnology company focused on drug discovery and drug development, especially known for its mRNA technology, which was crucial in developing one of the first COVID-19 vaccines. This breakthrough has propelled Moderna into the spotlight, showcasing its potential in harnessing mRNA technology for vaccines against infectious diseases, oncology, and other therapeutic areas. With an objective to create a new generation of transformative medicines for patients worldwide, Moderna is dedicated to advancing the science of mRNA while expanding its portfolio through ongoing projects in various stages of development. The company works tirelessly on innovation to address unmet medical needs, aiming for significant impacts on global health through its groundbreaking research.